Identification of bacterial contaminants in polyherbal medicines used for the treatment of tuberculosis in Amatole District of the Eastern Cape Province, South Africa, using rapid 16S rRNA technique

Journal of Health, Population and Nutrition

Volumn 35, Issue 1, 2016, Pages

  Famewo, Elizabeth Bosede ^a   Clarke, Anna Maria ^a   Afolayan, Anthony Jide ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Bacteria; Polyherbal medicines; Public health; Sequencing; Tuberculosis

Indexed keywords

BACTERIAL DNA; PLANT EXTRACT; RNA 16S;

BACTERIUM; DRUG CONTAMINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOCOMPROMISED PATIENT; MEDICINAL PLANT; MICROBIOLOGY; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; SOUTH AFRICA; TUBERCULOSIS;

BACTERIA; DNA, BACTERIAL; DRUG CONTAMINATION; HUMANS; IMMUNOCOMPROMISED HOST; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SOUTH AFRICA; TUBERCULOSIS;

EID: 85015227325     PISSN: 16060997     EISSN: 20721315     Source Type: Journal    
DOI: 10.1186/s41043-016-0064-y     Document Type: Article

References (61)

1. Louw CAM, Regnier TJC, Korsten L. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. J Ethnopharmacol. 2002;82(2):147-54.
2. Buwa LV, Afolayan AJ. Antimicrobial activity of some medicinal plants used for the treatment of tuberculosis in the Eastern Cape Province, South Africa. Afr J Biotechnol. 2009;8:23.
3. Lawal IO, Grierson DS, Afolayan AJ. Phytotherapeutic information on plants used for the treatment of tuberculosis in Eastern Cape Province, South Africa. Evid Based Complement Altern Med. 2014. doi: 10.1155/2014/735423.
4. Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A. Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis. 2011;204(4):1168-78.
5. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva: WHO; 2009.
6. Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K, Churchyard G. Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberculosis Lung Dis. 2009;13(1):39-46.
7. Wood R, Liang H, Wu H, Middelkoop K, Oni T, Rangaka MX, Lawn SD. Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberculosis Lung Dis. 2010;14(4):406-12.
8. Loddenkemper R, Hauer B. Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch Arztebl Int. 2010;107(1-2):10.
9. Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis. 2012;54(4):579-81.
10. Sloan DJ, Davies GR, Khoo SH. Recent advances in tuberculosis: new drugs and treatment regimens. Curr Res Med Rev. 2013;9(3):200.
11. World Health Organization: Treatment of Tuberculosis: Guildlines for National Programmes. Third Edition. WHO Geneva, 2003. (WHO/CDS/TB 2003.313).
12. Orodho JA, Kirimuhuzya C, Otieno JN, Magadula JJ, Okemo P. Local management of tuberculosis by traditional medicine practitioners in Lake Victoria Region. Open Complement Med J. 2011;3:1-9.
13. Alwakeel S. Microbial and heavy metals contamination of herbal medicines. Res J Microbiol. 2008;3(12):683-91.
14. Kaume L, Foote JC, Gbur EE. Microbial contamination of herbs marketed to HIV-infected people in Nairobi (Kenya). South Afr J Sci. 2012;108(9-10):1-4.
15. Ting A, Chow Y, Tan W. Microbial and heavy metal contamination in commonly consumed traditional Chinese herbal medicines. J Tradit Chin Med. 2013;33(1):119-24.
16. Noor R, Huda N, Rahman F, Bashar T, Munshi SK. Microbial contamination in herbal medicines available in Bangladesh. Bangladesh Med Res Counc Bull. 2014;39(3):124-9.
17. Adeleye IA, Okogi G, Ojo EO. Microbial contamination of herbal preparations in Lagos, Nigeria. J Health Popul Nutr. 2011;23(3):296-7.
18. Govender S, Du Plessis-Stoman D, Downing TG, Van de Venter M. Traditional herbal medicines: microbial contamination, consumer safety and the need for standards: research letter. South Afr J Sci. 2006;102(5 & 6):253.
19. Candlish AAG, Pearson SM, Aidoo KE, Smith JE, Kelly B, Irvine H. A survey of ethnic foods for microbial quality and content aflatoxin. Food Addit Contam. 2001;18(2):129-36.
20. Kneifel W, Czech E, Kopp B. Microbial contamination of medicinal plants-a review. Planta Med. 2002;68(1):5-15.
21. Dei-Tutuwa D, Amuna P, Rahman MA. Rapid detection of microbial contamination in Ghanaian herbal medicines by PCR analysis. Ghana Med J. 2014;48(2):106-11.
22. Baker GC, Smith JJ, Cowan DA. Review and re-analysis of domain-specific 16S primers. J Microbiol Methods. 2003;55(3):541-55.
23. Zhang S, Hou S, Ma X, Qin D, Chen T. Culturable bacteria in Himalayan glacial ice in response to atmospheric circulation. Biogeosciences. 2007;4:1-9.
24. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112-20.
25. World Health Organization. Guidelines for assessing quality of herbal medicines with reference to contaminants and residue. Geneva: WHO; 2007.
26. De Freitas Araujo MG, Bauab TM. Microbial quality of medicinal plant materials. 2012. doi: 10.5772/51072.
27. Walckenaer E, Poirel L, Leflon-Guibout V, et al. Genetic and biochemical characterization of the chromosomal class A ß-lactamases of Raoultella (formerly Klebsiella) planticola and Raoutella ornithinolytica. Antimicrob Agents Chemother. 2004;48(1):305-12.
28. Seng P, Boushab BM, Romain F, Gouriet F, Bruder N, Martin C, Papazian L. Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature. Int J Infect Dis. 2016;45:65-71.
29. Hadano Y, Tsukahara M, Ito K, Suzuki J, Kawamura I, Kurai H. Roultella ornithinolytica bacteremia in cancer patients: report of three cases. Int Med. 2012;51(22):3193-5.
30. Nakasone ES, Kaneshiro R, Min K, Tokeshi J. Emergence of Raoultella ornithinolytica on O 'ahu: a case of community-acquired R. ornithinolytica urinary tract infection. Hawai'i J Med Public Health. 2015;74(5):174.
31. Sandal G, Ozen M. Fatal Raoultella ornithinolytica sepsis and purpura fulminans in a preterm newborn. Indian J Paediatr Dermatol. 2014;15(1):24-6.
32. Deeb LS, Bajaj J, Bhargava S, Alcid D, Pitchumoni CS. Acute suppuration of the pancreatic duct in a patient with tropical pancreatitis. Case Rep Gastroenterol. 2008;2(1):27-32.
33. Solak Y, Gul EE, Atalay H, Genc N, Tonbul HZ. A rare human infection of Raoultella ornithinolytica in a diabetic foot lesion. Ann Saudi Med. 2011;31(1):93-4.
34. Morais VP, Daporta MT, Bao AF, Campello MG, Andrés GQ. Enteric fever-like syndrome caused by Raoultella ornithinolytica (Klebsiella ornithinolytica). J Clin Microbiol. 2009;47(3):868-9.
35. Vos B, Laureys M. Giant renal cyst as cause of colic obstruction. Rev Med Brux. 2009;30(2):107-9.
36. Lehloenya R, Christians S. A case of chronic urticaria complicated by Raoultella ornithi nolytica urinary tract infection, bronchospasm, and angioedema. World Allergy Organ J. 2012;5(2):204.
37. Caroff N, Chamoux C, Le Gallou F, Espaze E, Gavini F, Gautreau D, Reynaud A. Two epidemiologically related cases of Rahnella aquatilis bacteremia. European J Clin Microbiol Infect Dis. 1998;17(5):349-52.
38. Kuzdan C, Soysal A, özdemir H, Coskun S, Akman I, Bilgen H, Bakir M. Rahnella aquatilis sepsis in a premature newborn. Case Rep Paediatr. 2015.
39. Ash C, Farrow JA, Dorsch M, Stackenbrandt E, Collins MD. Comparative analysis of Bacillus anthracis, Bacillus cereus, and related species on the basis of reverse transcriptase of 16S rRNA. Int J Syst Bacteriol. 1991;41:343-6.
40. Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23:382-98.
41. Hilliard NJ, Schelonka RL, Waites KB. Bacillus cereus bacteremia in a preterm neonate. J Clin Microbiol. 2003;41:3441-4.
42. Kamar R, Gohar M, Jéhanno I, Réjasse A, Kallassy M, Lereclus D, Ramarao N. Pathogenic potential of Bacillus cereus strains as revealed by phenotypic analysis. J Clin Microbiol. 2013;51(1):320-3.
43. Kotiranta A, Lounatmaa K, Haapasalo M. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect. 2000;2(2):189-98.
44. Lerner BW, Lee Lerner K, editors. Anthrax infectious diseases: in context. 2008. p. 41-7.
45. Janda JM, Abbott SL. The genera Klebsiella and Raoultella. The Enterobacteria. 2nd ed. Washington: ASM Press; 2006. p. 115-29.
46. Rosenblueth M, Martinez L, Silva J, Martinez-Romero E. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst Appl Microbiol. 2004;27(1):27-35.
47. Maatallah M, Vading M, Kabir MH, Bakhrouf A, Kalin M, Nauclér P, Giske CG. Klebsiella variicola is a frequent cause of bloodstream infection in the Stockholm area, and associated with higher mortality compared to K. pneumoniae. PLoS One. 2014;9(11):113539.
48. Donnarumma F, Indorato C, Mastromei G, Goti E, Nicoletti P, et al. Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy. Eur J Clin Microbiol Infect Dis. 2011;31:371-8.
49. Yusuf I, Arzai AH, Umah A, Magaji N, Salisu N, Tukur A, Hamid KM. Prevalence of extended spectrum beta lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae in tuberculosis patients in Kano, Nigeria. Bayero J Pure Applied Sci. 2011;4(2):182-5.
50. Andino A, Hanning I. Salmonella enterica: survival, colonization, and virulence differences among serovars. Sci World J. 2015.
51. Blot SI, Vandewoude KH, Colardyn FA. Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest J. 2003;123(4):1208-13.
52. Hoffmann H, Roggenkamp A. Population genetics of the nomenspecies Enterobacter cloacae. Appl Environ Microbiol. 2003;69(9):5306-18.
53. Nishijima KA, Wall MM, Siderhurst MS. Demonstrating pathogenicity of Enterobacter cloacae on macadamia and identifying associated volatiles of gray kernel of macadamia in Hawaii. Plant Dis. 2007;91(10):1221-8.
54. Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 2012;7(7):887-902.
55. Lee CC, Lee NY, Yan JJ, Lee HC, Chen PL, Chang CM, Ko WC. Bacteremia due to extended-spectrum-ß-lactamase-producing Enterobacter cloacae: role of carbapenem therapy. Antimicrobial Agents Chemother. 2010;54(9):3551-6.
56. Osei-Adjei G, Hackman HK, Mills-Robertson FC, Tay SCK. Quality assessment of aqueous herbal/medicinal products sold on the Ghanaian market. Food Sci Qual Manage. 2013;20:13-8.
57. Baur R. Quality criteria and standardization of phytopharmaceuticals: can acceptable drugs standard be achieved? Drugs Inf J. 1998;32:101-10.
58. American Public Health Association (APHA). Standard methods for the examination of water and wastewater. 18th ed. Washington D.C: American Public Health Association; 1992. p. 9-66. Table 9225: I.
59. Pelczar Jr MJ, Chan EC, Nee R. A textbook of microbiology. International edition. 1993.
60. Jay JM. Modern food microbiology. Fifth Edition. Aspen Publishers, Inc, Maryland. 2012;633. doi:10.1007/978-1-4615-7476-7.
61. Ouyang J, Pei Z, Lutwick L, Dalal S, Yang L, Cassai N, Pincus MR. Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis. Ann Clin Lab Sci. 2008;38(4):393-400.